A dull end to a record-breaking week

Published 30-JAN-2017 15:03 P.M.


2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

The end to a record-breaking week in global markets was somewhat of an anti-climax with US markets spending most of the session in negative territory and finishing down seven points at 20,093 points.

The NASDAQ was only up slightly, finishing the week at 5660 points.

While newswires were flooded with pictures of President Trump signing executive orders there weren’t any policy documents delivered that could potentially sway markets, and Trump’s Twitterlogue was relatively quiet.

Markets were mixed in Europe with no firm leads as the FTSE 100 closed up 0.3%, while the Dax gave up 0.3% and the Paris CAC 40 finished down 0.6%.

Consequently, it is difficult to see the ASX taking any direction from overseas trends, and it is quite likely that the first few trading days could be driven by domestic data with all-important business conditions, business confidence and housing affordability figures to be released on Tuesday.

There was little movement on the commodities front as gold was relatively flat, finishing just under the US$1200 mark, a range it had traded in the vicinity of for most of the week.

Early support for the oil price waned as crude closed at US$53.20 per barrel, representing a decline of circa 1%.

There was also a lack of direction in base metals with copper and nickel gaining ground, while zinc and lead came off slightly. Importantly, copper finished within a cent of its 30 day high.

It is worth noting that 30 day LME copper warehouse stock levels continued to decline last week, suggesting there could be further upside in the near term.

The Australian dollar continues to hover in the vicinity of US$0.755.

It should be noted that broker projections and price targets are only estimates and may not be met. Also, historical data in terms of earnings performance and/or share trading patterns should not be used as the basis for an investment as they may or may not be replicated. Those considering this stock should seek independent financial advice.

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free